TrialJournal of translational medicine2019

Selective improvement by rifaximin of changes in the immunophenotype in patients who improve minimal hepatic encephalopathy.

Alba Mangas-Losada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.